Commentary on: CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma

Aesthet Surg J. 2023 Feb 3;43(2):147-149. doi: 10.1093/asj/sjac297.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast Implantation* / adverse effects
  • Breast Implants* / adverse effects
  • Humans
  • Interleukin-13 / metabolism
  • Ki-1 Antigen / metabolism
  • Lymphoma, Large-Cell, Anaplastic* / etiology
  • Lymphoma, Large-Cell, Anaplastic* / pathology
  • STAT6 Transcription Factor / metabolism

Substances

  • Interleukin-13
  • Ki-1 Antigen
  • STAT6 protein, human
  • STAT6 Transcription Factor